Demonstrating time sequence and extent of sustained decrease in native heart ejection fraction after heterotopic transplantation

Journal of Heart and Lung Transplantation

Volumn 23, Issue 6, 2004, Pages 690-695

  Sivaratnam, Dinesh A ^a   Kelly, Michael J ^a   Esmore, Don ^a   Richardson, Meroula ^a   Kalff, Victor ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; GATED IMAGING; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; HUMAN; MITRAL VALVE; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; GATED BLOOD-POOL IMAGING; HEART; HEART TRANSPLANTATION; HUMANS; POSTOPERATIVE PERIOD; STROKE VOLUME; TIME FACTORS; TRANSPLANTATION, HETEROTOPIC; VENTRICULAR FUNCTION, LEFT;

EID: 2642556984     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.07.014     Document Type: Article

References (23)

1. McMurray J.J., Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart. 83:2000;596-602
2. Deng M.C. Cardiac transplantation. Heart. 87:2002;177-184
3. Swedberg K. Consensus Trial Study Group. Effects of Enalapril on mortality in severe congestive cardiac failure. N Engl J Med. 316:1987;1429-1435
4. Packer M., Coats A.J., Fowler M.B., et al. Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of Cavedilol on survival in severe chronic heart failure. N Engl J Med. 344:2001;1651-1658
5. Sandner S.E., Weiselthaler G., Grimm M., et al. Survival benefit of cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation. 104:(suppl I):2001;H71-H76
6. Westaby S. Non-transplant surgery for heart failure. Heart. 83:2000;603-610
7. Hosenpud J.D., Bennett L.E., Keck B.M., et al. The registry of the International Society for Heart and Lung Transplantation Eighteenth official report - 2000. J Heart Lung Transplant. 20:2001;805-815
8. Kadner A., Chen R.H., Adams D.H. Heterotopic heart transplantation Experimental development and clinical experience. Eur J Cardiothoracic Surg. 17:2000;474-481
9. Farrar D.J., Holman W.R., McBride L.R., et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant. 21:2002;516-521
10. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 345:2001;1435-1443
11. Bleasdale R.A., Banner N.R., Anyanwu A.C., Mitchell A.G., Khaghani A., Yacoub M.H. Determinants of outcome after heterotopic heart transplantation. J Heart Lung Transplant. 21:2002;867-873
12. Tevaearai H.T., Walton G.B., Eckhart A.D., Keys J.R., Koch W.J. Heterotopic transplantation as a model to study functional recovery of unloaded failing hearts. J Thorac Cardiovasc Surg. 124:2002;1149-1156
13. Tagusari O., Kormos R.L., Griffith B.P., et al. Native heart complications after heterotopic heart transplantation Insight into the potential risk of left ventricular assist device. J Heart Lung Transplant. 18:1999;1111-1119
14. Callahan R.J., Froelich J.W., McKulski K.A., Leppo J., Strauss H.W. A modified method for the in vivo labeling of red blood cells with Tc-99m. J Nucl Med. 23:1982;315-318
15. Kelly M.J., Cowie A.R., Antonino A., Barton H., Kalff V. An assessment of factors influencing the effectiveness of the modified in vivo Technetium-99m-erythrocyte labeling technique in clinical use. J Nucl Med. 33:1992;2222-2225
16. Allen M.D., Corrie A., Stinson E.B., et al. Noninvasive assessment of donor and native heart function after heterotopic transplantation. J Thorac Cardiovasc Surg. 95:1988;75-81
17. Cowell R.P., Morris-Thurgood J., Yacoub M., et al. Effects of paced counterpulsation on exercise capacity and hemodynamics after heterotopic heart transplantation. Am J Cardiol. 75:1995;415-417
18. Morris-Thurgood J., Cowell R., Yacoub M., et al. Hemodynamic and metabolic effects of paced linkage following heterotopic cardiac transplantation. Circulation. 90:1994;2342-2347
19. Olivari M.T., Levine T.B., Ring W.S., Simon A., Cohn J.N. Normalization of sympathetic nervous system function after orthotopic cardiac transplant in man. Circulation. 76:1987;V62-V64
20. Delgado R. III, Radovancevic B., Massin E.K., Frazier O.H., Benedict C. Neurohormonal changes after implantation of a left ventricular assist system. ASAIO J. 44:1998;299-302
21. Haas G.J., Wooding-Scott M., Binkley P.F., Myerowitz P.D., Kelley R., Cody R.J. Effects of successful cardiac transplantation on plasma endothelin. Am J Cardiol. 71:1993;237-240
22. Lerman A., Kubo S.H., Tschumperlin L.K., Burnett J.C. Jr. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol. 20:1992;849-853
23. Maybaum S., Williams M., Mancini D., et al. Assessment of synchrony relationship between the native left ventricle and the HeartMate left ventricular assist device. J Heart Lung Transplant. 21:2002;509-515